Resapp have stated on a few occasions that they do not at this stage intend to release a version of the product for the patient's personal use. It is a diagnostic tool to assist a medical practitioner. As such there will be a qualified medical person available to assess modify the environment if conditions are outside the operating tolerance of the product. In a traditional setting the medic will be able to intervene directly to fix problems. In a telehealth context, where the doctor and the patient are in different locations, they will be able to advise the patient on what they need to do to reduce interference to a tolerable level before they collect new data.
- Forums
- ASX - By Stock
- RAP
- of interest
of interest, page-15
Featured News
Add RAP (ASX) to my watchlist
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable